Source: Virtual Congress 2021 – Pathogenic progress in airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ferrarotti (Pavia , Italy), I. Belmonte (Barcelona, Spain), M. Balduyck (Lille, France), T. Carroll (Dublin, Ireland), A. Corsico (Pavia, Italy), T. Greulich (Marburg, Germany), N. Mcelvaney (Dublin, Ireland), M. Miravitlles (Barcelona, Italy), M. Odou (Lille, France), S. Ottaviani (Pavia, Italy), F. Rodríguez-Frías (Barcelona, Spain), A. Rozy (Warsaw, Poland), S. Seixas (Porto, Portugal), M. Veith (Marburg, Germany), F. Zerimech (Lille, France), J. Chorostowska-Wynimko (Warsaw, Italy). External quality assessment (EQA) for laboratory diagnosis of alpha1-antitrypsin deficiency (AATD) – Program driven by the European Alpha-1-Research Collaboration (EARCO) network. 2400

Member's Comments

No comment yet.

Related content which might interest you: Health status measurements in alpha-1antitrypsin deficiency (AATD) Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017 Year: 2018 Detection of alpha1-antitrypsin deficiency in a European country without national registry yet Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 The worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) ERS Clinical Research Collaboration Source: Eur Respir J, 53 (3) 1802228; 10.1183/13993003.02228-2018 Year: 2019 Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 The NIHR translational research collaboration: The relationship between CT densitometry and quality of life in alpha one antitrypsin deficiency Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019 Year: 2019 Asthma control index in European countries: The LIAISON (InternationaL cross-sectIonAl and longitudinal assessment on aSthma cONtrol) study cross-sectional results Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Research priorities in a1-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration Source: ERJ Open Res, 6 (4) 00523-2020; 10.1183/23120541.00523-2020 Year: 2020 The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018 Year: 2019 The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL) Source: Virtual Congress 2020 – Hot topics in paediatric asthma Year: 2020 Classification of clinical spirometry data using global lung initiative (GLI) and national health and nutrition examination survey (NHANES-III) models Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Symptom/risk assessment in alpha-1-antitrypsin deficiency (AATD) using the 2011 GOLD algorithm Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 GOLD ABCD assessment tool: Comparison of 2013 and 2017 classifications in the UK Clinical Practice Research Datalink (CPRD) Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Health Technology Assessment (HTA) core model: A method to evaluate TB policy in a tertiary specialized hospital for infectious diseases Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Preliminary results from Central Eastern European (CEE) AAT NETWORK Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Quality of randomised trials in COPD Source: Eur Respir J 2009; 34: 1060-1065 Year: 2009